STERIS plc (NYSE:STE) has a beta value of 0.55 and has seen 0.47 million shares traded in the last trading session. The company, currently valued at $21.75B, closed the last trade at $217.82 per share which meant it lost -$0.25 on the day or -0.11% during that session. The STE stock price is -3.76% off its 52-week high price of $226.00 and 28.39% above the 52-week low of $155.99. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.38 million shares traded. The 3-month trading volume is 511.71K shares.
The consensus among analysts is that STERIS plc (STE) is an Overweight stock at the moment, with a recommendation rating of 1.60. 0 analysts rate the stock as a Sell, while 1 rate it as Overweight. 0 out of 6 have rated it as a Hold, with 4 advising it as a Buy. 1 have rated the stock as Underweight. The expected earnings per share for the stock is $1.49.
STERIS plc (NYSE:STE) trade information
Sporting -0.11% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, 09/03/21 when the STE stock price touched $217.82 or saw a rise of 0.61%. Year-to-date, STERIS plc shares have moved 14.92%, while the 5-day performance has seen it change 1.97%. Over the past 30 days, the shares of STERIS plc (NYSE:STE) have changed 1.06%. Short interest in the company has seen 3.67 million shares shorted with days to cover at 5.08.
Wall Street analysts have a consensus price target for the stock at $249.60, which means that the shares’ value could jump 12.73% from current levels. The projected low price target is $239.00 while the price target rests at a high of $255.00. In that case, then, we find that the current price level is -17.07% off the targeted high while a plunge would see the stock gain -9.72% from current levels.
STERIS plc (STE) estimates and forecasts
Figures show that STERIS plc shares have outperformed across the wider relevant industry. The company’s shares have gained 26.16% over the past 6 months, with this year growth rate of 24.80%, compared to 16.90% for the industry. Other than that, the company has, however, increased its growth outlook for the 2021 fiscal year revenue. Growth estimates for the current quarter are 13.70% and 23.00% for the next quarter. Revenue growth from the last financial year stood is estimated to be 47.60%.
5 analysts offering their estimates for the company have set an average revenue estimate of $968.42 million for the current quarter. 5 have an estimated revenue figure of $1.15 billion for the next quarter concluding in Sep 2021. Year-ago sales stood $668.93 million and $722.87 million respectively for this quarter and the next, and analysts expect sales will grow by 44.80% for the current quarter and 59.30% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 24.40% over the past 5 years. Earnings growth for 2021 is a modest -2.80% while over the next 5 years, the company’s earnings are expected to increase by 10.00%.
STERIS plc is expected to release its next earnings report between October 04 and October 08 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 1.60 at a share yield of 0.73%. The company’s dividend yield has gone up over the past 12 months, with a 5 Year Average Dividend Yield of 1.14%.
STERIS plc (NYSE:STE)’s Major holders
Insiders own 0.37% of the company shares, while shares held by institutions stand at 98.02% with a share float percentage of 98.38%. Investors are also buoyed by the number of investors in a company, with STERIS plc having a total of 885 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 9.69 million shares worth more than $1.85 billion. As of Mar 30, 2021, Vanguard Group, Inc. (The) held 11.35% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 7.71 million shares as of Mar 30, 2021. The firm’s total holdings are worth over $1.47 billion and represent 9.03% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Investment Managers Ser Tr-WCM Focused International Growth Fd and Vanguard Total Stock Market Index Fund. As of Apr 29, 2021, the former fund manager holds about 3.22% shares in the company for having 2.75 million shares of worth $579.57 million while later fund manager owns 2.41 million shares of worth $459.07 million as of Mar 30, 2021, which makes it owner of about 2.82% of company’s outstanding stock.